Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Laura Anderson is active.

Publication


Featured researches published by Laura Anderson.


Systematic Reviews | 2014

The effectiveness of computerized order entry at reducing preventable adverse drug events and medication errors in hospital settings: a systematic review and meta-analysis

Teryl K. Nuckols; Crystal M. Smith-Spangler; Sally C. Morton; Steven M. Asch; Vaspaan Patel; Laura Anderson; Emily L Deichsel; Paul G. Shekelle

BackgroundThe Health Information Technology for Economic and Clinical Health (HITECH) Act subsidizes implementation by hospitals of electronic health records with computerized provider order entry (CPOE), which may reduce patient injuries caused by medication errors (preventable adverse drug events, pADEs). Effects on pADEs have not been rigorously quantified, and effects on medication errors have been variable. The objectives of this analysis were to assess the effectiveness of CPOE at reducing pADEs in hospital-related settings, and examine reasons for heterogeneous effects on medication errors.MethodsArticles were identified using MEDLINE, Cochrane Library, Econlit, web-based databases, and bibliographies of previous systematic reviews (September 2013). Eligible studies compared CPOE with paper-order entry in acute care hospitals, and examined diverse pADEs or medication errors. Studies on children or with limited event-detection methods were excluded. Two investigators extracted data on events and factors potentially associated with effectiveness. We used random effects models to pool data.ResultsSixteen studies addressing medication errors met pooling criteria; six also addressed pADEs. Thirteen studies used pre-post designs. Compared with paper-order entry, CPOE was associated with half as many pADEs (pooled risk ratio (RR) = 0.47, 95% CI 0.31 to 0.71) and medication errors (RR = 0.46, 95% CI 0.35 to 0.60). Regarding reasons for heterogeneous effects on medication errors, five intervention factors and two contextual factors were sufficiently reported to support subgroup analyses or meta-regression. Differences between commercial versus homegrown systems, presence and sophistication of clinical decision support, hospital-wide versus limited implementation, and US versus non-US studies were not significant, nor was timing of publication. Higher baseline rates of medication errors predicted greater reductions (P < 0.001). Other context and implementation variables were seldom reported.ConclusionsIn hospital-related settings, implementing CPOE is associated with a greater than 50% decline in pADEs, although the studies used weak designs. Decreases in medication errors are similar and robust to variations in important aspects of intervention design and context. This suggests that CPOE implementation, as subsidized under the HITECH Act, may benefit public health. More detailed reporting of the context and process of implementation could shed light on factors associated with greater effectiveness.


Sexually Transmitted Diseases | 1997

Predictors of human immunodeficiency virus counseling and testing among sexually transmitted disease clinic patients.

Sandra Schwarcz; Christopher Spitters; Michele M. Ginsberg; Laura Anderson; Timothy A. Kellogg; Mitchell H. Katz

Objectives: To determine the predictors of prior or current, and repeat human immunodeficiency virus (HIV) testing. Study Design: Cross‐sectional survey. Methods: Sexually transmitted disease (STD) clinic patients who participated in a blinded HIV seroprevalence survey completed a voluntary questionnaire regarding their reasons for accepting or declining HIV testing. Results: Eighty‐seven percent of participants reported a previous HIV test or were HIV testing the day they completed the questionnaire. African Americans were less likely to have been HIV tested (adjusted odds ratio 0.3, 95% confidence limits 0.1, 0.8). The most common reasons for testing were to be reassured and to receive medical care if infected. The most common reason for not testing was that nontesters did not think that they were infected. Repeat testing was reported by 51% of the participants and was more frequent among patients who were older or members of high‐risk groups (P < 0.05). Patients tested repeatedly to confirm a prior HIV test result or because of continued risky behavior. Conclusions: Testing for HIV is frequent among STD clinic patients but less so among African Americans. Receipt of medical care appears to be an important motivation for HIV testing, whereas lack of perceived risk may discourage testing. Continued high‐risk behavior contributes to repeat HIV testing.


JAMA Internal Medicine | 2017

Economic Evaluation of Quality Improvement Interventions Designed to Prevent Hospital Readmission: A Systematic Review and Meta-analysis

Teryl K. Nuckols; Emmett B. Keeler; Sally C Morton; Laura Anderson; Brian Doyle; Joshua M. Pevnick; Marika Booth; Roberta Shanman; Aziza Arifkhanova; Paul G. Shekelle

Importance Quality improvement (QI) interventions can reduce hospital readmission, but little is known about their economic value. Objective To systematically review economic evaluations of QI interventions designed to reduce readmissions. Data Sources Databases searched included PubMed, Econlit, the Centre for Reviews & Dissemination Economic Evaluations, New York Academy of Medicines Grey Literature Report, and Worldcat (January 2004 to July 2016). Study Selection Dual reviewers selected English-language studies from high-income countries that evaluated organizational or structural changes to reduce hospital readmission, and that reported program and readmission-related costs. Data Extraction and Synthesis Dual reviewers extracted intervention characteristics, study design, clinical effectiveness, study quality, economic perspective, and costs. We calculated the risk difference and net costs to the health system in 2015 US dollars. Weighted least-squares regression analyses tested predictors of the risk difference and net costs. Main Outcomes and Measures Main outcomes measures included the risk difference in readmission rates and incremental net cost. This systematic review and data analysis is reported in accordance with Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Results Of 5205 articles, 50 unique studies were eligible, including 25 studies in populations limited to heart failure (HF) that included 5768 patients, 21 in general populations that included 10 445 patients, and 4 in unique populations. Fifteen studies lasted up to 30 days while most others lasted 6 to 24 months. Based on regression analyses, readmissions declined by an average of 12.1% among patients with HF (95% CI, 8.3%-15.9%; P < .001; based on 22 studies with complete data) and by 6.3% among general populations (95% CI, 4.0%-8.7%; P < .001; 18 studies). The mean net savings to the health system per patient was


Sexually Transmitted Infections | 2016

Cost-effectiveness of HIV and syphilis antenatal screening: a modelling study

Claire C. Bristow; Elysia Larson; Laura Anderson; Jeffrey D. Klausner

972 among patients with HF (95% CI, −


JAMA Internal Medicine | 2016

Economic Evaluation of Quality Improvement Interventions for Bloodstream Infections Related to Central Catheters: A Systematic Review

Teryl K. Nuckols; Emmett B. Keeler; Sally C Morton; Laura Anderson; Brian Doyle; Marika Booth; Roberta Shanman; Jonathan Grein; Paul G. Shekelle

642 to


Diabetes Care | 2018

Economic Evaluation of Quality Improvement Interventions Designed to Improve Glycemic Control in Diabetes: A Systematic Review and Weighted Regression Analysis

Teryl K. Nuckols; Emmett B. Keeler; Laura Anderson; Jonas B. Green; Sally C Morton; Brian Doyle; Kanaka D Shetty; Aziza Arifkhanova; Marika Booth; Roberta Shanman; Paul G. Shekelle

2586; P = .23; 24 studies), and the mean net loss was


Sexually Transmitted Diseases | 2017

Comparative Evaluation of 2 Nucleic Acid Amplification Tests for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae at Extragenital Sites

Claire C. Bristow; Mark R. McGrath; Adam Carl Cohen; Laura Anderson; Kristie K. Gordon; Jeffrey D. Klausner

169 among general populations (95% CI, −


American Journal of Preventive Medicine | 2018

The Cost of Interventions to Increase Influenza Vaccination: A Systematic Review

Laura Anderson; Paul G. Shekelle; Emmett B. Keeler; Lori Uscher-Pines; Roberta Shanman; Sally C Morton; Gursel Aliyev; Teryl K. Nuckols

2610 to


Journal of Nursing Administration | 2017

Clinical Effectiveness and Cost of a Hospital-Based Fall Prevention Intervention: The Importance of Time Nurses Spend on the Front Line of Implementation

Teryl K. Nuckols; Jack Needleman; Tristan Grogan; Li-Jung Liang; Pamela Worobel-Luk; Laura Anderson; Linda Czypinski; Courtney Coles; Catherine M. Walsh

2949; P = .90; 21 studies), reflecting nonsignificant differences. Among general populations, interventions that engaged patients and caregivers were associated with greater net savings (


Annals of Internal Medicine | 2014

Opioid Prescribing: A Systematic Review and Critical Appraisal of Guidelines for Chronic Pain

Teryl K. Nuckols; Laura Anderson; Ioana Popescu; Allison Diamant; Brian Doyle; Paul Di Capua; Roger Chou

1714 vs −

Collaboration


Dive into the Laura Anderson's collaboration.

Top Co-Authors

Avatar

Teryl K. Nuckols

Cedars-Sinai Medical Center

View shared research outputs
Top Co-Authors

Avatar

Brian Doyle

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Emmett B. Keeler

Frederick S. Pardee RAND Graduate School

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge